ABUS—This dual-nuc trial was announced back in June (#msg-164648753), so it took six months to dose the first patient. I continue to question the merit of using two nucs and think that ABUS is flailing.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.